Literature DB >> 10647669

A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995.

P C Albertsen1, S Walters, J A Hanley.   

Abstract

PURPOSE: We quantified the agreement between the underlying cause of death determination from information in hospital medical records and on death certificates, and determined whether the frequency of assigning death from prostate cancer had changed since the introduction of testing for prostate specific antigen.
MATERIALS AND METHODS: We retrospectively reviewed and analyzed the information in hospital medical records and on death certificates for men previously diagnosed with prostate cancer who died in 1985 or 1995.
RESULTS: The underlying cause of death determinations from a review of 201 hospital medical records agreed with those from information on part 1 of the death certificate in 87% of cases and with those using the International Classification of Diseases-9 system coding rules in 80%. Agreement was higher in men who were older than those who were younger at the time of death, and higher in those diagnosed with prostate cancer several years before death than in those diagnosed shortly before death.
CONCLUSIONS: There was a high level of agreement concerning the underlying cause of death after a review of the information in hospital medical records and on death certificates for men with prostate cancer when cause of death was viewed as a dichotomous variable. The International Classification of Diseases-9 coding rules concerning the underlying cause of death favor overreporting rather than underreporting prostate cancer deaths compared with a review of hospital medical records. Cause of death determination does not appear to have changed after the introduction of prostate specific antigen testing.

Entities:  

Mesh:

Year:  2000        PMID: 10647669

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  30 in total

1.  Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.

Authors:  Grace Lu-Yao; Peter C Albertsen; Janet L Stanford; Therese A Stukel; Elizabeth S Walker-Corkery; Michael J Barry
Journal:  BMJ       Date:  2002-10-05

2.  The changing age distribution of prostate cancer in Canada.

Authors:  C Ineke Neutel; Ru-Nie Gao; Paul A Blood; Leslie A Gaudette
Journal:  Can J Public Health       Date:  2007 Jan-Feb

3.  Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.

Authors:  Grace L Lu-Yao; Peter C Albertsen; Dirk F Moore; Weichung Shih; Yong Lin; Robert S DiPaola; Siu-Long Yao
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

4.  Determining stroke's rank as a cause of death using multicause mortality data.

Authors:  James F Burke; Lynda D Lisabeth; Devin L Brown; Matthew J Reeves; Lewis B Morgenstern
Journal:  Stroke       Date:  2012-07-19       Impact factor: 7.914

5.  Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.

Authors:  Sigrid Carlsson; Melissa Assel; David Ulmert; Axel Gerdtsson; Jonas Hugosson; Andrew Vickers; Hans Lilja
Journal:  Eur Urol       Date:  2016-04-13       Impact factor: 20.096

6.  Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians.

Authors:  Roger Valdivieso; Katharina Boehm; Malek Meskawi; Alessandro Larcher; Zhe Tian; Marie-Elise Parent; Philip Wong; Markus Graefen; Francesco Montorsi; Maxine Sun; Fred Saad; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2015-04-09       Impact factor: 4.226

7.  Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer.

Authors:  Katharina Boehm; Paolo Dell'Oglio; Zhe Tian; Umberto Capitanio; Felix K H Chun; Derya Tilki; Axel Haferkamp; Fred Saad; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2016-10-28       Impact factor: 4.226

8.  Impact of comorbidity on survival among men with localized prostate cancer.

Authors:  Peter C Albertsen; Dirk F Moore; Weichung Shih; Yong Lin; Hui Li; Grace L Lu-Yao
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

9.  Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project.

Authors:  V Paul Doria-Rose; Pamela M Marcus
Journal:  Lung Cancer       Date:  2008-06-30       Impact factor: 5.705

10.  Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.

Authors:  Yu-Hsuan Shao; Dirk F Moore; Weichung Shih; Yong Lin; Thomas L Jang; Grace L Lu-Yao
Journal:  BJU Int       Date:  2013-01-17       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.